John Mack looks at GSK’s campaign for alli (OTC orlistat).
Related Stories
More in Uncategorized
Comments
Previous post: Avandia and GSK: Trial data
Next post: A blog’s lifespan
John Mack looks at GSK’s campaign for alli (OTC orlistat).
Previous post: Avandia and GSK: Trial data
Next post: A blog’s lifespan
